CC BY-NC-ND 4.0 · Rev Bras Ginecol Obstet 2017; 39(06): 265-272
DOI: 10.1055/s-0037-1603646
Original Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Syphilis in Pregnancy and Congenital Syphilis: Reality in a Portuguese Central University Hospital

Sífilis na gravidez e sífilis congênita: realidade de um hospital universitário central português
Magda Magalhães
1   Obstetric Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
,
Lígia Basto
2   Pediatric Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
,
Ana Luísa Areia
1   Obstetric Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
,
Sofia Franco
1   Obstetric Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
,
Maria Eugénia Malheiro
1   Obstetric Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
,
Maria Eulália Afonso
2   Pediatric Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
,
Paulo Moura
1   Obstetric Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
3   Vice-Dean of Medicine Faculty, Universidade de Coimbra, Coimbra, Portugal
› Author Affiliations
Further Information

Publication History

07 January 2017

14 March 2017

Publication Date:
13 June 2017 (online)

Abstract

Purpose To evaluate maternal-fetal surveillance and follow-up of infants at risk for congenital syphilis (CS).

Methods Retrospective cohort study in a Portuguese Tertiary Referral Hospital. The main inclusion criterion was a positive syphilis serology. The study included all pregnant women that delivered in our hospital between January 2004 and December 2013. The neonates were classified according to their probability of infection based on the Centers for Disease Control and Prevention guidelines.

Results Among the 27 pregnancies at risk for CS, 48.2% (n = 13) of the women had a diagnosis during the 1st trimester, and the median gestational age at the end of the treatment was 28 weeks. Inadequate treatment was noted in 44.4% (n = 12) of the women. Adverse pregnancy outcomes were observed in 30.8% of the cases (n = 8), 5 of which had been adequately treated. We found 2 (7.7%) cases with “proven or highly probable CS,” 10 (38.5%) with “possible CS,” 12 (46.1%) with “less likely CS,” and 2 (7.7%) with “unlikely CS.” Among the infants, the treatment was successful, except for 1 neurosyphilis case.

Conclusion This study highlights many of the difficulties/concerns encountered in the maternal-neonatal management of syphilis. We highlight the importance of assuring the early detection of the infection as a way of guaranteeing the timely treatment, as well as a good compliance to the treatment and follow-up through a more efficient pregnant women surveillance network.

Resumo

Objetivo Avaliar a vigilância materno-fetal e o acompanhamento de crianças em risco de sífilis congênita (SC).

Métodos Estudo de coorte retrospetivo desenvolvido num hospital terciário de referência, cujo principal critério de inclusão foi a presença de serologia positiva para sífilis. O estudo incluiu todas as grávidas admitidas no nosso Hospital entre janeiro de 2004 e dezembro de 2013. Os recém-nascidos foram classificados de acordo com a probabilidade de infeção, com base nas recomendações do Centers for Disease Control and Prevention.

Resultados Entre as 27 gravidezes em risco de SC, 48,2% (n = 13) tiveram diagnóstico durante o 1° trimestre; a idade gestacional média no final do tratamento foi de 28 semanas. Em 44,4% (n = 12) das mulheres, o tratamento foi considerado inadequado. Em 30,8% dos casos (n = 8) houve algum evento adverso da gravidez, dos quais 5 foram adequadamente tratados. Em dois dos casos (7,7%) a SC foi provada ou considerada como altamente provável, 10 (38,5%) com SC provável, 12 (46,1%) com SC pouco provável, e 2 (7,7%) com SC improvável. Nos lactentes, o tratamento foi bem sucedido, com exceção de um caso de neurossífilis.

Conclusão Este estudo visa realçar muitas das dificuldades/preocupações encontradas na vigilância materno-neonatal dos casos com diagnóstico de sífilis. ublinhamos, não só, a importância de se assegurar a deteção precoce de infeção como forma de se garantir o tratamento atempado, mas também, uma adequada adesão à vigilância/tratamento, através de uma rede mais eficiente entre as diferentes instituições envolvidas no acompanhamento das grávidas.

 
  • References

  • 1 Gao J, Xu J, Sheng Y. , et al. Increasing trend of syphilis and infection resistance: a retrospective study. Int J Infect Dis 2013; 17 (11) e971-e976
  • 2 European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report 2014 - sexually transmitted infections, including HIV and blood-borne viruses. Stockholm: ECDC; 2015
  • 3 European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report 2014–Congenital Syphilis. Stockholm: ECDC; 2015
  • 4 Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 2013; 91 (03) 217-226
  • 5 Le Chevalier de Préville M, Alessandri JL, Traversier N, Cuillier F, Robin S, Ramful D. Evaluation of the management of pregnancies and infants at risk for congenital syphilis: La Réunion, 2008 to 2014. J Perinatol 2017; 37 (02) 116-121
  • 6 Centers for Disease Control and Prevention [Internet]. Sexually transmitted diseases treatment guidelines. 2015 [cited 2016 Nov 12]. Available from: < https://www.cdc.gov/std/tg2015/ >
  • 7 Direção-Geral da Saúde. Norma DGS n° 037/2011 de 30/09/2011 atualizada a 20/12/2013. Lisboa: DGS; 2013
  • 8 Public Health Agency of Canada [Internet]. Canadian guidelines on sexually transmitted infections. Section 5 - Management and treatment of specific infections: syphilis. 2014 [cited 2016 Nov 12]. Available from: < http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/section-5-10-eng.php >
  • 9 Braccio S, Sharland M, Ladhani SN. Prevention and treatment of mother-to-child transmission of syphilis. Curr Opin Infect Dis 2016; 29 (03) 268-274
  • 10 Chen ZQ, Zhang GC, Gong XD. , et al. Syphilis in China: results of a national surveillance programme. Lancet 2007; 369 (9556): 132-138
  • 11 Finelli L, Berman SM, Koumans EH, Levine WC. Congenital syphilis. Bull World Health Organ 1998; 76 (Suppl. 02) 126-128
  • 12 Kiss H, Widhalm A, Geusau A, Husslein P. Universal antenatal screening for syphilis: is it still justified economically? A 10-year retrospective analysis. Eur J Obstet Gynecol Reprod Biol 2004; 112 (01) 24-28
  • 13 Hawkes SJ, Gomez GB, Broutet N. Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis. PLoS One 2013; 8 (02) e56713
  • 14 Saloojee H, Velaphi S, Goga Y, Afadapa N, Steen R, Lincetto O. The prevention and management of congenital syphilis: an overview and recommendations. Bull World Health Organ 2004; 82 (06) 424-430
  • 15 Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003; 189 (03) 861-873
  • 16 Rawstron SA, Hawkes SJ. Treponema pallidum (Syphilis). In: Long S, Prober C, Pickering L. , editors. Principles and practice of pediatric infectious diseases. New York: Elsevier; 2011. . p. 941-947
  • 17 Sheffield JS, Sánchez PJ, Morris G. , et al. Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 2002; 186 (03) 569-573
  • 18 Silva S, Henriques R, Gomes JP, Borrego MJ, Afonso E. Could we miss congenital neurosyphilis?. Lancet Infect Dis 2012; 12 (10) 816